Patent

# NameRegistration [Patent ID]Note
23 Compositions and Method for Treating or Preventing Fibrosis PCT/IB2019/001136 fibrosis treatment
22 Methods for producing in vitro wilson's disease model using human pluripotent stem cell and in vitro wilson's disease model produced by thereof 10-2159877/ KR
PCT/KR2019/001278
Wilson's dsease model
21 Composition for predicting prognosis of senere alcoholic hepatitis and use thereof 10-2171799/ KR
PCT/KR2019/002392
Biomarker for alcholic hepatitis
20 Method for differentiation of hepatocyte 10-2038503/ KR Hepatic maturation
19 Method for enhancing metabolizing activity of hepatocytes 10-2018783/ KR Hepatic differentiation
18 Composition for Idiopathic Pulmonary Fibrosis treatment or prevention containing recombinant protein for Idiopathic Pulmonary Fibrosis treatment or prevention 10-2161892/ KR
PCT/KR2018/012801
Use of NP-011 for IPF disease
17 Composition for Alzheimer"s disease treatment or prevention containing recombinant protein for Alzheimer"s disease treatment or prevention 10-2129179/ KR
PCT/KR2018/012800
Use of NP-011 for Alzheimer"s disease
16 Composition for myocardial infarction treatment or prevention containing recombinant protein for myocardial infarction treatment or prevention 10-2129178/ KR
PCT/KR2018/012780
Use of NP-011 for MI disease
15 Methods for differentiation of glutamatergic neuron from human plufipotent stem cell using insulin-like growth factor 1 receptor inhibitor 10-2183230/ KR
PCT/KR2019/007266
Neural differentiation
14 Simple method for differentiating human pluripotent stem cells into highly proliferative vascular endothelial cells for hemophilia A treatment 10-2161910/ KR Vascular endothlial cells differentiation
13 Methods for preparing in vitro cultured hepatocytes using er stress reliever and in vitro cultured hepatocytes prepared by thereof
(Partition application: primary Hepatocytes)
10-2145134/ KR Hepatocyte cultivation
12 Methods for preparing in vitro cultured hepatocytes using er stress reliever and in vitro cultured hepatocytes prepared by thereof(Partition application: liver cancer cells) 10-2159886/ KR Hepatocyte cultivation
11 Methods for preparing in vitro cultured hepatocytes using er stress reliever and in vitro cultured hepatocytes prepared by thereof 10-2060256/ KR
PCT/KR2018/012609
Hepatocyte cultivation
10 Method for generating human pluripotent stem cells derived functional cardiomyocytes by cell differentiation with maturation and hauman pluripotent stem cell derived functional cardiomyocytes generated by thereof 10-1994035/ KR
PCT/KR2018/004195
Differentiation and production of mature cardiomyocytes
9 Recombinant protein for treatment or prevention and composition for treatment or prevention containing thereof(Partition application: Excluding signal peptide ) 2019-160324/ JP NP-011 and the use of NP-001 for curing liver disease
  1. 1
  2. 2
  • logoCONTACT

    Contact Information

    • Address: 8F, 55 Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea(07802)

    • Business Registration No.: 109-86-37282
    • CEO: Choongseong Han

    • Tel: +82-2-2088-8886
    • Fax: +82-2-2088-8884
    • E-mail: support@nexel.co.kr